ZNF563 Inhibitors

The compounds identified as ZNF563 inhibitors primarily target mechanisms associated with gene transcription and modulation. T A subset of these inhibitors, including Trichostatin A and SAHA, are HDAC inhibitors, which can alter the chromatin structure, thereby affecting the binding of transcription factors like ZNF563 to DNA.

Compounds such as 5-Azacytidine and RG108, on the other hand, inhibit DNA methyltransferases. These enzymes control DNA methylation, a key epigenetic modification that influences gene expression. By altering the methylation status of DNA, the binding affinity or the interaction of transcription factors with their target DNA sequences can be changed. Furthermore, direct inhibitors of the transcription process, like Alpha-amanitin and Actinomycin D, halt transcription by targeting RNA polymerase or intercalating DNA. The effect of these compounds can influence a broad spectrum of transcription factors, including ZNF563. JQ1 and I-BET151 are BET bromodomain inhibitors. The BET family of proteins often serve as readers of acetylated lysine residues on histones, playing roles in facilitating gene transcription. By inhibiting these proteins, the transcriptional landscape of the cell can be shifted.